Literature DB >> 2988945

Role of exoenzyme S in chronic Pseudomonas aeruginosa lung infections.

T I Nicas, D W Frank, P Stenzel, J D Lile, B H Iglewski.   

Abstract

Exoenzyme S is an extracellular ADP-ribosyltransferase enzyme produced by Pseudomonas aeruginosa. Mutants of Pseudomonas aeruginosa deficient in this enzyme have been shown to have reduced virulence in infections of burned mice. The contribution of exoenzyme S to the pathogenesis of chronic lung infections with this organism was evaluated by examining the incidence of exoenzyme S production by Pseudomonas aeruginosa strains isolated from cystic fibrosis patients and comparing an exoenzyme S deficient mutant and its exoenzyme S producing parent in a rat chronic lung infection model. Of 51 isolates examined, 43% produced detectable levels of exoenzyme S. While both the exoenzyme S deficient mutant and its parent strain were equally capable of colonizing and persisting in rat lungs, the exoenzyme S producing parent elicited a greater degree of lung damage. These data suggest that exoenzyme S contributes to the pathogenesis of chronic lung infections.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2988945     DOI: 10.1007/bf02013593

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  18 in total

1.  Pseudomonas aeruginosa exoenzyme S: an adenosine diphosphate ribosyltransferase distinct from toxin A.

Authors:  B H Iglewski; J Sadoff; M J Bjorn; E S Maxwell
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Pseudomonas: the compromised host.

Authors:  R E Wood
Journal:  Hosp Pract       Date:  1976-08

4.  Production of exoenzyme S during Pseudomonas aeruginosa infections of burned mice.

Authors:  M J Bjorn; O R Pavlovskis; M R Thompson; B H Iglewski
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

5.  Isolation and characterization of transposon-induced mutants of Pseudomonas aeruginosa deficient in production of exoenzyme S.

Authors:  T I Nicas; B H Iglewski
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

6.  Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains.

Authors:  R E Hancock; L M Mutharia; L Chan; R P Darveau; D P Speert; G B Pier
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

7.  Exotoxin production by clinical isolates of pseudomonas aeruginosa.

Authors:  M Pollack; N S Taylor; L T Callahan
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

8.  Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases.

Authors:  N Holby; S Olling
Journal:  Acta Pathol Microbiol Scand C       Date:  1977-04

9.  Contribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats.

Authors:  D E Woods; S J Cryz; R L Friedman; B H Iglewski
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

10.  Contribution of exoenzyme S to the virulence of Pseudomonas aeruginosa.

Authors:  T I Nicas; B H Iglewski
Journal:  Antibiot Chemother (1971)       Date:  1985
View more
  26 in total

1.  Differential sensitivity of human epithelial cells to Pseudomonas aeruginosa exoenzyme S.

Authors:  E M McGuffie; J E Fraylick; D J Hazen-Martin; T S Vincent; J C Olson
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

2.  Ras effector pathway activation by epidermal growth factor is inhibited in vivo by exoenzyme S ADP-ribosylation of Ras.

Authors:  M L Henriksson; R Rosqvist; M Telepnev; H Wolf-Watz; B Hallberg
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

3.  O-antigen serotypes and type III secretory toxins in clinical isolates of Pseudomonas aeruginosa.

Authors:  Karine Faure; David Shimabukuro; Temitayo Ajayi; Leonard R Allmond; Teiji Sawa; Jeanine P Wiener-Kronish
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

4.  Evolving stealth: genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections.

Authors:  Dao Nguyen; Pradeep K Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-22       Impact factor: 11.205

Review 5.  Quorum-sensing blockade as a strategy for enhancing host defences against bacterial pathogens.

Authors:  Thomas Bjarnsholt; Michael Givskov
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-07-29       Impact factor: 6.237

6.  ADP-ribosylation of p21ras and related proteins by Pseudomonas aeruginosa exoenzyme S.

Authors:  J Coburn; D M Gill
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

7.  Pseudomonas aeruginosa exoenzyme S stimulates murine lymphocyte proliferation in vitro.

Authors:  N G Barclay; J C Spurrell; T F Bruno; D G Storey; D E Woods; C H Mody
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 8.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

9.  Expression of recombinant exoenzyme S of Pseudomonas aeruginosa.

Authors:  S M Kulich; D W Frank; J T Barbieri
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

10.  Effect of metabolic imbalance on expression of type III secretion genes in Pseudomonas aeruginosa.

Authors:  Arne Rietsch; Matthew C Wolfgang; John J Mekalanos
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.